Abstract Submission Information

 

Topics:
Submitted abstracts should focus on clinical and/or basic science aspects of insulin resistance, Obesity and Diabetes
 

Clinical Science:
Clinical Aspects of Insulin Resistance Across Lifespan and Exploring the spectrum of Diabetes-Obesity-CardioRenal-Fatty Liver and Related Metabolic Conditions. Covering insulin resistance's clinical dimensions in childhood, adolescence, and adulthood.  Encompassing the areas of diabetes, obesity, Metabolic Syndrome, Dyslipidemia, Hypertension & Resistant Hypertension, Atherosclerosis, cardiovascular disease, Heart Failure, Peripheral Vascular Disease, Insulin Resistance and Obesity related malignancies, liver disease-MASLD/MASH, Chronic Kidney Disease, Clinical Manifestation of Hypercortisolism, Sexual Hormones abnormalities i.e. PCOS or male hypogonadism, Lung Disease including obstructive sleep apnea and related sleep disorders.
 

Basic Science:
Investigate mechanisms underlying insulin resistance, inflammation, endothelial and vascular anomalies, and metabolic dysfunction in pivotal centers like the beta cell, adipocyte, gut, and brain. Multi-hormonal aspects of obesity, gut hormones – e.g. incretins, other hormones impacting to energy balance- i.e. Amylin, and the influence of circadian rhythms on metabolic mechanisms.
 

Guidelines:
WCIRDC is keen on exploring Basic and Clinical science studies related to insulin action/resistance, Obesity, Diabetes and the whole milieu of CardioRenal and Metabolic Diseases. To align with these guidelines, authors are encouraged to provide a brief explanation of how their topic relates to insulin resistance and/or the aforementioned metabolic processes.

​

Special Notice:
All abstracts submitted are being checked for plagiarism and AI generated material. Of note, the software is able to identify plagiarism based on all international journals. Abstracts that will be identified as such will not be published and the authors will be barred from future submission. 
 

View a sample abstract submission from the PDF below:

​

​

​

 

​

          

​

​

​

Abstract Poster Presentations:

Accepted abstracts can be presented as posters at the conference. Authors or presenters for poster presentations must be registered participants. The presenter must be one of the authors listed on the abstract.
Eligibility for Publication:

Abstracts and scientific material presented at the conference must not have been published or presented prior to December 4, 2025.  To be eligible for publication, at least one author of the accepted abstract must be a registered participant of the 23rd WCIRDC and must have presented the abstract in person at the conference. Encore Abstracts are not eligible for publication. 

 

Encore Abstracts:

Encore abstracts are accepted and can appear at the poster hall.  but will not be published in ‘Metabolism’ journal  and will not be eligible for oral abstract presentations or awards. Make sure to identify your abstract as an Encore if it was published or presented in a different conference.  In addition, upon acceptance of your encore abstract, at least one of the authors should be registered for the conference and is present on-site to present their posters during the meeting.

 

Abstract Oral Presentations:

Six of the highest-ranking abstracts will be chosen for the Abstract Oral Presentation Session. Authors of winning abstracts will present their research findings in a 10-minute presentation, followed by a 5-minute Q&A session. If selected, authors are required to register for the meeting and prepare a PowerPoint presentation.
 

Top Abstract Awards:

The highest-ranking abstracts will receive awards at different levels:

Gold, Silver, Bronze, and honorable mentions. Award recipients will be chosen from the Abstract Oral Winners.

Encore Abstracts are not eligible for awards. 

​​​

 

Important Information:
The deadline for submission of late-breaking abstracts is November 24, 2025 at 11:59 PM, Pacific Standard Time.  

Abstracts and scientific material presented at the conference must not have been published or presented prior to December 4, 2025.
Abstracts must be submitted electronically and should not exceed 250 words.

Tables, graphs, figures, or references should not be included.

Abstracts will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
Poster guidelines, including presentation size and layout details, can be found at wcir.org/poster-guidelines.
If an author wishes to make changes or withdraw their abstract, they must notify the WCIRDC team no later than November 24, 2025. Requests submitted after this date may not be accommodated.

 

Travel Grants for International Participants:

The WCIRDC is pleased to offer a travel grant program for international physicians

who are practicing outside of the United States of America (USA).

Click on the link to see if you qualify: 

https://www.wcir.org/travel-grants